Drugs / EE
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04134715 | Oct 2019 → Jan 2020 | — | Pfizer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EE | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04134715 ↗ |
| Route | Oral | “orally starting from Period 2 Day 1 until Period 3-Day 16” NCT04134715 ↗ |